PROSTATE CANCER AND IMAGING IN CLINICAL TRIALS
Prostate cancer is the second most common cancer in men worldwide. Its incidence is expected to rise with the growth and aging of the population. Known risk factors are age, ethnicity, and genetics.
Prostate cancer remains a major health concern worldwide, and imaging has become essential in improving its diagnosis and management. In this eBook, we explore the critical role of imaging in prostate cancer clinical trials, with a focus on PET tracers, tumor response evaluation, and Keosys’s contributions to advancing imaging in oncology research.